Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.39 |
| ▸ | TSHR | P16473 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22808139 | 0.84 | ATM (0.46) | ATMCYP3A4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL20830130 | 0.78 | PPARA (0.37) | ATMCYP3A4CTSLCTSBCTSS | |
| SCHEMBL8857090 | 0.77 | ATM (0.55) | ATMSYKCTSLCTSBCTSS | |
| SCHEMBL8857340 | 0.77 | ATM (0.55) | ATMSYKCTSLCTSBCTSS | |
| SCHEMBL8857439 | 0.77 | ATM (0.55) | ATMSYKCTSLCTSBCTSS | |
| SCHEMBL26451040 | 0.76 | SYK (0.50) | ATMCASP1SYKCTSLCTSB | |
| SCHEMBL1199787 | 0.76 | ITGB3 (0.53) | ATMALDH1A1SYKCTSLCTSB | |
| SCHEMBL1199790 | 0.76 | ITGB3 (0.53) | ATMALDH1A1SYKCTSLCTSB | |
| SCHEMBL7513292 | 0.76 | ITGB3 (0.53) | ATMALDH1A1SYKCTSLCTSB | |
| SCHEMBL1199066 | 0.75 | KYNU (0.54) | ATMALDH1A1SYKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10870671-B2 | Method of preparation of alpha galactosyl ceramides compounds | ABIVAX (FR) | 2020-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10870671-B2 | Method of preparation of alpha galactosyl ceramides compounds | UGCG, GBA1, MAN2B1 | ATM 4668/4885CYP3A4 2855/4885TSHR 2567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.